Weeks of TIL Therapy 'Buys Years' to Next Melanoma Treatment, Expert Says

Treatment with Amtagvi, a TIL therapy recently approved for advanced melanoma, includes a three-week hospital stay upfront, but may lead to years of monitoring without more treatment needed, an expert explained.

Related Keywords

Texas ,United States ,Nina Mcdonald ,Rodaben Amaria ,Moffitt Cancer Center ,Mcdonald ,University Of Texas Md Anderson Cancer Center ,Drug Administration ,Cancer Center ,Cell Manufacturing ,Side Effect ,News ,Melanoma ,Til Therapy ,Melanoma Treatment ,Amtagvi ,